Keloid showdown: which injection flattens scars best?
NCT ID NCT07420166
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compared two injected treatments for keloid scars: triamcinolone acetonide (a steroid) and verapamil hydrochloride (a blood pressure drug). Sixty adults with keloids received injections every three weeks for up to eight sessions. The goal was to see which treatment better flattened and improved the scar's appearance.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- triamcinolone acetonide and verapamil hydrochloride
- What this could lead to
- If one treatment works better, it could offer a more effective option for flattening keloid scars.
- What could go wrong
- This is a small, completed study with only 60 people. Results may not apply to everyone, and both treatments have possible side effects like pain or skin changes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KELOID are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bahawal Victoria Hospital/Quaid-e-Azam Medical College
Bahawalpur, Punjab Province, 63100, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Sound waves and herbs take on 'Non-Killing Cancer' of keloid scars
- Do future doctors know the skin risks of tattoos and piercings?
- New PET scan tracer could spot keloids without a biopsy
- Can a simple ointment before surgery lead to better scars?
- Plasma zaps scars: new device aims to smooth skin
- 7,000 volunteers needed to crack the genetic code of keloids.